Verge Genomics logo

Verge Genomics Funding & Investors

Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases.

vergegenomics.com

Total Amount Raised: $134,120,000

Verge Genomics Funding Rounds

  • Series B

    $98,000,000

    Series B Investors

    Tao Capital Partners
    Vulcan Capital
    Alumni Ventures
    Eli Lilly
    Merck
    Section 32
    Lifeforce Capital
    ALS Investment Fund
    BlackRock
    Threshold Ventures
  • Series A

    $32,000,000

    Series A Investors

    Tao Capital Partners
    Alumni Ventures
    Lifeforce Capital
    Castor Ventures
    ALS Investment Fund
    Threshold Ventures
    WuXi AppTec Co
    Basis Set Ventures
    Agent Capital
    Jonathan Downey
    Great Oaks Venture Capital
    Fitz Gate Ventures
    OS Fund
  • Seed

    $4,000,000

    Seed Investors

    IA Ventures
    Two Sigma Ventures
    Slow Ventures
    Karlin Ventures
    Kimberly Vogel
    Refactor Capital
    Great Oaks Venture Capital
    Lifeforce Capital
    Draper Associates
    OS Fund
  • Pre Seed

    $120,000

    Pre Seed Investors

    Y Combinator
Funding info provided by Diffbot.